drugset / Trial / NCT01867606

Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery

NCT01867606 ↗

Phase 2 Completed 58 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindSupportive care

Summary

This randomized pilot phase II trial studies how well serum bovine immunoglobulin protein isolate works in improving quality of life and post-operative recovery in patients with cancer of the female reproductive tract after undergoing surgery. Serum bovine immunoglobulin may help provide nutrition to patients who are not able to eat or digest ordinary food. This may improve the quality of life of patients with gynecological cancer and help them recover more quickly from surgery.

Timeline

Start
2013-10-04
Primary completion
2015-11-21
Completion
2015-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject serum-derived bovine immunoglobulin protein isolate Protein / enzyme biologic — Oral